The theoretical issue is that you somehow engender cross-immunogenicity when switching back and forth between multiple different generics. With complex proteins that are all a bit different from each other it is a potential concern.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.